The Global Burden of Cancer Is Rising—But Not Equally
Published in Cancer
Explore the Research
Just a moment...
jamanetwork.com
Cancer remains one of the leading causes of morbidity and mortality worldwide. But how is the burden evolving—and where is it growing the fastest?
In this large-scale analysis from the Global Burden of Disease (GBD) 2019 Study, published in JAMA Oncology, we gain a comprehensive picture of global cancer trends across 204 countries over the past decade.
🌍 Study Overview
- Data from 204 countries and territories
- Analysis period: 2010–2019
- Outcomes measured:
- Incidence
- Mortality
- Years of life lost (YLLs)
- Years lived with disability (YLDs)
- Disability-adjusted life years (DALYs)
📊 Key Findings
• Global cancer burden is increasing
– 23.6 million new cases in 2019
– 10 million deaths
– 250 million DALYs
• Significant rise over the decade
– Cases ↑ 26.3%
– Deaths ↑ 20.9%
– DALYs ↑ 16%
• Cancer is now the 2nd leading cause of death and disease burden globally (after cardiovascular diseases)
• Disparities by Socio-demographic Index (SDI)
– High SDI countries: highest incidence
– Middle SDI countries: highest mortality and DALYs
– Low & low-middle SDI: fastest growth in cases and deaths
• Disability burden is increasing
– Greater contribution of YLDs to DALYs in higher SDI regions
💡 Key Takeaways
This study highlights a critical reality:
➡️ Cancer burden is not only increasing—but shifting
- Low-resource settings are experiencing the fastest growth
- Mortality remains disproportionately high in middle SDI regions
- Survivorship—and thus disability burden—is rising in high SDI countries
⚖️ What This Means for Global Health
- Urgent need for equitable cancer control strategies
- Strengthening early detection and treatment access in lower SDI regions
- Expanding focus beyond survival to include quality of life and disability
- Data-driven policy is essential to address regional disparities
📄 Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups (2010–2019)
JAMA Oncology (2022)
DOI: 10.1001/jamaoncol.2021.6987
Global Burden of Disease 2019 Cancer Collaboration
Article links:
https://pubmed.ncbi.nlm.nih.gov/34967848/
https://jamanetwork.com/journals/jamaoncology/fullarticle/2787350
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in